RT Journal Article
SR Electronic
T1 Anti-SARS-CoV-2 IgG antibodies are associated with reduced viral load
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.22.20110551
DO 10.1101/2020.05.22.20110551
A1 Bryan, Andrew
A1 Fink, Susan L.
A1 Gattuso, Meghan A.
A1 Pepper, Gregory
A1 Chaudhary, Anu
A1 Wener, Mark H.
A1 Morishima, Chihiro
A1 Jerome, Keith R.
A1 Mathias, Patrick C.
A1 Greninger, Alexander L.
YR 2020
UL http://medrxiv.org/content/early/2020/05/24/2020.05.22.20110551.abstract
AB Anti-SARS-CoV-2 antibodies have been described, but correlation with virologic outcomes is limited. Here, we find anti-SARS-CoV-2 IgG to be associated with reduced viral load. High viral loads were rare in individuals who had seroconverted. Higher viral load on admission was associated with increased 30-day mortality (OR 4.20 [95% CI: 1.62-10.86]).Competing Interest StatementALG reports personal fees from Abbott Molecular, outside of the submitted work.Funding StatementThis work was funded by the Department of Laboratory MedicineAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:UW IRB approved this work with a consent waiverAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesDeidentified data is available from authors under reasonable request.